Arun azad discussed psmaddition, a phase iii trial of [177 lu]lu-psma-617 combined with androgen deprivation therapy (adt) plus an androgen receptor pathway inhibitor (arpi) in patients with psma … Lutetium-177 (lu-177) psma therapy (pluvicto) is a new theranostic treatment that targets a specific molecule on the surface of prostate cancer cells, effectively killing the cancer cells while preserving …